Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
This Wichita program is helping KC startups connect the dots to corporate partners
WICHITA — An eight-week program targeting knowledge and access gaps between emerging startups and enterprise companies helped boost a trio of Kansas City ventures whose founders are now eying new customers and partners as they scale. The 2023 NXTSTAGE Enterprise Engagement Series — an initiative of Wichita-based NXTUS — wrapped its latest cohort during Wichita Startup…
Shop Small: 5 gifts for people who are always cold
Editor’s note: This feature is the third in Startland News’ five-part holiday gift guide — presented in 2023 by nbkc bank — showcasing Kansas City makers and their products. Check out the featured maker below, then keep reading for five gift ideas to get started. Donnell Jamison’s colorful streetwear brand shares a similar retro vibe…
Let’s be blunt: MO cannabis culture is a great niche, founder says a year after legalization vote
A year after Missouri voters approved recreational marijuana at the ballot box, demand for high-quality cannabis products has exceeded expectations, said Michael Wilson, whose Kansas City-based operation quickly became a best-selling Show-Me State brand. “The past year has been a wild ride as anyone can suspect from an early emerging market like cannabis,” said Wilson,…
Urban farmer’s composting operation gets in ‘deep trouble’ with city; why she’s thankful for the opportunity to cultivate change
Being pioneers on the Kansas City urban farming scene can be a tough row to hoe, admitted Brooke Salvaggio noting the challenges she’s faced with Urbavore Farm and Compost Collective KC are just the latest season on an evolving agricultural landscape. “More or less, we’re rebels,” explained Salvaggio, who along with her husband, Dan Heryer,…